AMIX Autonomix Medical, Inc. Common Stock
Healthcare$0.40+0.00%ClosedMarket Cap: $2.1M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.42
P/S
0.00
EV/EBITDA
0.46
DCF Value
$4.81
FCF Yield
-524.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-228.8%
ROA
-168.8%
ROIC
-205.0%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 null | $0.00 | $-3.3M | $— |
| Q2 null | $0.00 | $-7.5M | $— |
| Q1 null | $0.00 | $-3.3M | $— |
| Q4 null | $0.00 | $-3.2M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Maxim GroupBuy
2026-02-17Trading Activity
Insider Trades
View AllSmith Trent N.officer: CFO
SellWed Aug 13
Smith Trent N.officer: CFO
SellWed Aug 13
KLEMP WALTER Vdirector
SellWed Aug 13
Hauser Bradleyofficer: CEO and President
SellWed Aug 13
Capelli Christopherdirector
SellWed Aug 13
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
-1.80
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.